Indravadan Patel

Edoxaban versus Warfarin in Patients with Atrial Fibrillation

Robert P. Giugliano, Christian T. Ruff, Eugene Braunwald et al. · New England Journal of Medicine · 2013 · 5.1K citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +17

Evaluation of the novel factor Xa inhibitor edoxaban compared with warfarin in patients with atrial fibrillation: Design and rationale for the Effective aNticoaGulation with factor xA next GEneration in Atrial Fibrillation–Thrombolysis In Myocardial Infarction study 48 (ENGAGE AF–TIMI 48)

Christian T. Ruff, Robert P. Giugliano, Elliott M. Antman et al. · American Heart Journal · 2010 · 482 citations

Medicine, Cardiology, Pharmacology +14

Association between edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial

Christian T. Ruff, Robert P. Giugliano, Eugene Braunwald et al. · The Lancet · 2015 · 399 citations

Pharmacy, Pharmacology, Pharmacotherapy +10

Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation

Stuart J. Connolly, Indravadan Patel, Daniel E. Salazar et al. · Thrombosis and Haemostasis · 2010 · 343 citations

Medicine, Pharmacology, Pharmacotherapy +12

Left atrial structure and function in atrial fibrillation: ENGAGE AF-TIMI 48

Deepak K. Gupta, Amil M. Shah, Robert P. Giugliano et al. · European Heart Journal · 2013 · 212 citations

Medicine, Cardiology, Health Sciences +17